Human Wnt/β-Catenin Regulates Alloimmune Signaling during Allogeneic Transplantation.
Ontology highlight
ABSTRACT: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most widely applied forms of adoptive immunotherapy for the treatment of hematological malignancies. Detrimental graft-versus-host disease (GVHD), but also beneficial graft-versus-leukemia (GVL) effects occurring after allo-HSCT are largely mediated by alloantigen-reactive donor T cells in the graft. Separating GVHD from GVL effects is a formidable challenge, and a greater understanding of donor T cell biology is required to accomplish the uncoupling of GVHD from GVL. Here, we evaluated the role of β-catenin in this process. Using a unique mouse model of transgenic overexpression of human β-catenin (Cat-Tg) in an allo-HSCT model, we show here that T cells from Cat-Tg mice did not cause GVHD, and surp
SUBMITTER: Mammadli M
PROVIDER: S-EPMC8345079 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA